Synovate acquires healthcare research specialist ISIS.
8 October 2003
LONDON — SYNOVATE, the market research division of Aegis Group plc, announced that it has acquired ISIS Research Limited (ISIS), a leading international healthcare research business. ISIS will become a key part of Synovate Healthcare, Synovate's global healthcare specialist division.
ISIS provides some of the world's largest pharmaceutical companies with syndicated and custom healthcare research including cancer care audits in five key European markets as well as Japan. The acquisition of the healthcare specialist complements Synovate's existing Tandem Cancer Audit in the US, with whom ISIS are now conducting a global cancer audit. It also adds strengths in other syndicated areas including HIV and diabetes.
"Last month our clients welcomed the news of Synovate Healthcare joining forces with ISIS on a global cancer audit," says Synovate worldwide CEO Adrian Chedore. This enabled us to create the world's first truly aligned global cancer audit and offer clients significant purchasing economies made possible by such a cooperation.
"The global cancer audit is but one example of what we can do with our combined capabilities and knowledge. With ISIS in the fold, Synovate Healthcare's market positioning and benefits to healthcare clients are much more robust."
Colin Maitland, CEO of ISIS who will be heading up Synovate Healthcare, says, "Joining Synovate gives us a future with much greater opportunities for growth, and wider career opportunities than we had before. It will also give our clients more and better market research products and services. We look forward to the challenges that face us in building this global healthcare division into the market leader that Synovate wants us to become."
Contact(s) for this press release
|
Alicia Kan
Global Head of Communications |
|
Telephone: +1 312 526 4570 |
Synovate generates consumer insights that drive competitive marketing solutions. The network provides clients cohesive global support and a comprehensive suite of research solutions. Synovate employs 3,000 staff in over 80 offices across 47 countries. More information on Synovate can be found on www.synovate.com.
About ISISISIS Research was established in 1973 in the UK and has subsequently grown into an international healthcare research company with subsidiaries and branches in the US, Europe and Asia Pacific. The company provides research services to many of the world's leading pharmaceutical companies.